Inventor
PITZEN JENNIFER
US11 patents
Patents
11 patentsUS11739074B2Aug 29, 2023
Ras inhibitors
REVOLUTION MEDICINES INC9 citations84
US11364300B2Jun 21, 2022
C40-, C28-, and C-32-linked rapamycin analogs as mTOR inhibitors
REVOLUTION MEDICINES INC6 citations84
US10980889B1Apr 20, 2021
C40-, C28-, and C-32-linked rapamycin analogs as mTOR inhibitors
REVOLUTION MEDICINES INC8 citations81
US12252497B2Mar 18, 2025
Ras inhibitors
REVOLUTION MEDICINES INC3 citations73
US12048749B2Jul 30, 2024
C40-, C28-, and C-32-linked rapamycin analogs as mTOR inhibitors
REVOLUTION MEDICINES INC3 citations73
US12187746B2Jan 7, 2025
C26-linked rapamycin analogs as mTOR inhibitors
REVOLUTION MEDICINES INC5 citations72
US11685749B2Jun 27, 2023
C26-linked rapamycin analogs as mTOR inhibitors
REVOLUTION MEDICINES INC5 citations72
US12544448B2Feb 10, 2026
C40-, C28-, and C-32-linked rapamycin analogs as mTOR inhibitors
REVOLUTION MEDICINES INC0 citations61
US12365688B2Jul 22, 2025
Substituted pyrazolopyrazines, imidazopyrazines and [1,2,4]triazolopyrazines as allosteric SHP2 inhibitors
REVOLUTION MEDICINES INC0 citations59
US11739093B2Aug 29, 2023
Substituted pyrazolopyrazines, imidazopyrazines and [1,2,4]triazolopyrazines as allosteric SHP2 inhibitors
REVOLUTION MEDICINES INC1 citations59
US11673901B2Jun 13, 2023
Polycyclic compounds as allosteric SHP2 inhibitors
REVOLUTION MEDICINES INC0 citations47